Simparica Trio

Why it is listed

Simparica Trio is an FDA-approved monthly chew for dogs that combines flea and tick control with heartworm prevention and intestinal nematode treatment. The current label also covers six tick species and flea-tapeworm prevention by killing fleas. It is prescription-only and carries the isoxazoline neurologic warning. Ask a veterinarian before use if the dog has a seizure history.

Pros & cons

Pros

• DailyMed / NADA 141-521: prevents heartworm disease; treats/controls roundworms and hookworms; kills adult fleas; labeled for six tick species including lone star and Asian longhorned; prevents Borrelia burgdorferi by killing Ixodes scapularis.
• Zoetis pet-owner page and 2025 label: prevents Dipylidium caninum (flea tapeworm) as a direct result of killing vector fleas; can be given with or without food.
• Dogs and puppies 8 weeks and older, from 2.8 lb — among the lowest weight floors on this list.

Cons

• Contains sarolaner (isoxazoline). FDA fact sheet and the Trio label warn of neurologic adverse reactions including seizures, including in dogs without a prior history. Use with caution if there is a seizure/neurologic history.
• Prescription only. Not a cat product. Does not replace environmental flea control for untreated pets in the house.
• We did not independently time ‘starts killing fleas within 4 hours’; that figure is from Zoetis/label studies, not our stopwatch.

Score breakdown